Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 3/20 | 0.36 |
| ▸ | JAK2 | O60674 | 11/20 | 0.36 |
| ▸ | JAK1 | P23458 | 11/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3923286 | 0.91 | TACR1 (0.38) | TACR1JAK2JAK1SLC6A4KCNH2 | |
| SCHEMBL3934412 | 0.91 | TACR1 (0.38) | TACR1JAK2JAK1SLC6A4KCNH2 | |
| SCHEMBL2425983 | 0.90 | JAK2 (0.38) | TACR1JAK2JAK1SLC6A4KCNH2 | |
| SCHEMBL3926859 | 0.90 | TACR1 (0.37) | TACR1JAK2JAK1SLC6A4KCNH2 | |
| SCHEMBL2423310 | 0.88 | JAK2 (0.36) | TACR1JAK2JAK1 | |
| SCHEMBL3935599 | 0.88 | TACR1 (0.37) | TACR1JAK2JAK1SLC6A4KCNH2 | |
| SCHEMBL12290807 | 0.88 | TACR1 (0.37) | TACR1JAK2JAK1SLC6A4KCNH2 | |
| SCHEMBL12290455 | 0.88 | TACR1 (0.37) | TACR1JAK2JAK1SLC6A4KCNH2 | |
| SCHEMBL3923863 | 0.87 | TACR1 (0.35) | TACR1SLC6A4KCNH2F2RL1CNR1 | |
| SCHEMBL2427186 | 0.87 | TACR1 (0.37) | TACR1JAK2JAK1SLC6A4KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009009411-A1 | SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-01-15 | — | — | WO | disclosed |